Home › NDC Lookup › RxCUI directory › RxCUI 2641650

0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz] — RxCUI 2641650

RxNorm drug concept · Semantic branded drug
RxCUI 2641650 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2641650
Official name0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHyrimoz 10 MG per 0.1 ML Prefilled Syringe; Hyrimoz 10 MG in 0.1 ML Prefilled Syringe
FDA products mapped6
Package NDCs mapped10
Reported Medicaid activity (SDUD)216 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Adalimumab is approved for quite a few inflammatory conditions — rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psor...
  • What conditions is adalimumab actually approved to treat?
  • You'll use either an autoinjector pen or a prefilled syringe, depending on what your doctor prescribes. Before injecting, take it out of the refrigerator and let it sit for 15 to 3...
  • How do I give myself this injection at home?
📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How 0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz] RxCUI 2641650

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Adalimumab 327361
    • Adalimumab-adaz 2641642
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hyrimoz 2641646
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adalimumab Prefilled Syringe 727702
    • Adalimumab-adaz Prefilled Syringe 2649231
    • Adalimumab Injectable Product 1163691
    • Adalimumab-adaz Injectable Product 2662733
    • Adalimumab Prefilled Syringe [Hyrimoz] 2641649
    • Adalimumab-adaz Prefilled Syringe [Hyrimoz] 2656267
    • Hyrimoz Injectable Product 2641648
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syringe SCD · 2641644
  • Adalimumab-adaz 100 MG/ML SCDC · 2641643
  • Adalimumab Prefilled Syringe SCDF · 727702
  • Adalimumab-adaz Prefilled Syringe SCDFP · 2649231
  • Adalimumab Injectable Product SCDG · 1163691
  • Adalimumab-adaz Injectable Product SCDGP · 2662733

Brand-Name Concepts

  • Adalimumab-adaz 100 MG/ML [Hyrimoz] SBDC · 2641647
  • Adalimumab Prefilled Syringe [Hyrimoz] SBDF · 2641649
  • Adalimumab-adaz Prefilled Syringe [Hyrimoz] SBDFP · 2656267
  • Hyrimoz Injectable Product SBDG · 2641648
  • Hyrimoz BN · 2641646

📦 FDA Products & Package NDCs

6 products · 10 package NDCs
10 package NDCs map to RxCUI 2641650 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61314-0454-20 2 SYRINGE in 1 CARTON (61314-454-20) / .8 mL in 1 SYRINGE HYRIMOZ Sandoz Inc 2023-07-01
61314-0454-36 3 SYRINGE in 1 CARTON (61314-454-36) / .8 mL in 1 SYRINGE HYRIMOZ Sandoz Inc 2023-07-01
61314-0454-68 3 SYRINGE, GLASS in 1 CARTON (61314-454-68) / .8 mL in 1 SY... HYRIMOZ Sandoz Inc 2023-07-01
61314-0473-20 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE HYRIMOZ Sandoz Inc 2023-07-01
61314-0473-64 2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SY... HYRIMOZ Sandoz Inc 2023-07-01
61314-0473-92 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE HYRIMOZ Sandoz Inc 2023-07-01
61314-0476-64 2 SYRINGE, GLASS in 1 CARTON (61314-476-64) / .2 mL in 1 SY... HYRIMOZ Sandoz Inc 2023-07-01
61314-0509-64 2 SYRINGE, GLASS in 1 CARTON (61314-509-64) / .1 mL in 1 SY... HYRIMOZ Sandoz Inc 2023-07-01
61314-0517-36 3 KIT in 1 CARTON (61314-517-36) / 1 KIT in 1 KIT * 1 SYRI... HYRIMOZ Sandoz Inc 2023-07-01
61314-0531-64 2 KIT in 1 CARTON (61314-531-64) / 1 KIT in 1 KIT * 1 SYRI... HYRIMOZ Sandoz Inc 2023-07-01
Observed labelers: Sandoz Inc (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.